Antibodies as carriers of cytotoxicity

Gespeichert in:
Bibliographische Detailangaben
Format: Buch
Sprache:English
Veröffentlicht: Basel ; München [u.a.] Karger 1992
Schriftenreihe:Beiträge zur Onkologie 43
Schlagworte:
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

MARC

LEADER 00000nam a2200000 cb4500
001 BV005345499
003 DE-604
005 20130624
007 t|
008 920624s1992 xx ad|| |||| 00||| eng d
020 |a 3805555997  |9 3-8055-5599-7 
035 |a (OCoLC)25992234 
035 |a (DE-599)BVBBV005345499 
040 |a DE-604  |b ger  |e rakwb 
041 0 |a eng 
049 |a DE-19  |a DE-12  |a DE-355  |a DE-29  |a DE-188  |a DE-578 
050 0 |a QP364.7 
082 0 |a 616.07/93  |2 20 
084 |a XH 1500  |0 (DE-625)152870:12905  |2 rvk 
084 |a XH 3200  |0 (DE-625)152888:12905  |2 rvk 
245 1 0 |a Antibodies as carriers of cytotoxicity  |c vol. ed. H.-H. Sedlacek ... 
264 1 |a Basel ; München [u.a.]  |b Karger  |c 1992 
300 |a VIII, 208 S.  |b Ill., graph. Darst. 
336 |b txt  |2 rdacontent 
337 |b n  |2 rdamedia 
338 |b nc  |2 rdacarrier 
490 1 |a Beiträge zur Onkologie  |v 43 
500 |a Literaturverz. S. [147] - 208 
650 4 |a Antibodies, Monoclonal  |x therapeutic use 
650 4 |a Antibody-toxin conjugates  |x Therapeutic use  |x Testing 
650 4 |a Cancer  |x Chemotherapy  |x Evaluation 
650 4 |a Cytotoxicity, Immunologic 
650 4 |a Neoplasms  |x therapy 
650 0 7 |a Cytotoxizität  |0 (DE-588)4193696-6  |2 gnd  |9 rswk-swf 
650 0 7 |a Monoklonaler Antikörper  |0 (DE-588)4040094-3  |2 gnd  |9 rswk-swf 
650 0 7 |a Antikörper  |0 (DE-588)4002290-0  |2 gnd  |9 rswk-swf 
650 0 7 |a Therapie  |0 (DE-588)4059798-2  |2 gnd  |9 rswk-swf 
650 0 7 |a Krebs  |g Medizin  |0 (DE-588)4073781-0  |2 gnd  |9 rswk-swf 
650 0 7 |a Arzneistoffträger  |0 (DE-588)4278196-6  |2 gnd  |9 rswk-swf 
650 0 7 |a Tumor  |0 (DE-588)4078460-5  |2 gnd  |9 rswk-swf 
689 0 0 |a Krebs  |g Medizin  |0 (DE-588)4073781-0  |D s 
689 0 1 |a Therapie  |0 (DE-588)4059798-2  |D s 
689 0 2 |a Monoklonaler Antikörper  |0 (DE-588)4040094-3  |D s 
689 0 3 |a Arzneistoffträger  |0 (DE-588)4278196-6  |D s 
689 0 |5 DE-604 
689 1 0 |a Antikörper  |0 (DE-588)4002290-0  |D s 
689 1 1 |a Cytotoxizität  |0 (DE-588)4193696-6  |D s 
689 1 |5 DE-604 
689 2 0 |a Tumor  |0 (DE-588)4078460-5  |D s 
689 2 1 |a Monoklonaler Antikörper  |0 (DE-588)4040094-3  |D s 
689 2 2 |a Cytotoxizität  |0 (DE-588)4193696-6  |D s 
689 2 3 |a Therapie  |0 (DE-588)4059798-2  |D s 
689 2 |5 DE-604 
700 1 |a Sedlacek, Hans-Harald  |d 1943-  |e Sonstige  |0 (DE-588)1029511926  |4 oth 
830 0 |a Beiträge zur Onkologie  |v 43  |w (DE-604)BV000000016  |9 43 
943 1 |a oai:aleph.bib-bvb.de:BVB01-003349792 

Datensatz im Suchindex

DE-19_call_number 0700/8 Med. 33957
DE-19_location 50
DE-BY-UBM_katkey 979942
DE-BY-UBM_media_number 41605688160017
_version_ 1823050517823094784
any_adam_object
author_GND (DE-588)1029511926
building Verbundindex
bvnumber BV005345499
callnumber-first Q - Science
callnumber-label QP364
callnumber-raw QP364.7
callnumber-search QP364.7
callnumber-sort QP 3364.7
callnumber-subject QP - Physiology
classification_rvk XH 1500
XH 3200
ctrlnum (OCoLC)25992234
(DE-599)BVBBV005345499
dewey-full 616.07/93
dewey-hundreds 600 - Technology (Applied sciences)
dewey-ones 616 - Diseases
dewey-raw 616.07/93
dewey-search 616.07/93
dewey-sort 3616.07 293
dewey-tens 610 - Medicine and health
discipline Medizin
format Book
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02421nam a2200637 cb4500</leader><controlfield tag="001">BV005345499</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20130624 </controlfield><controlfield tag="007">t|</controlfield><controlfield tag="008">920624s1992 xx ad|| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3805555997</subfield><subfield code="9">3-8055-5599-7</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)25992234</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV005345499</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield><subfield code="a">DE-12</subfield><subfield code="a">DE-355</subfield><subfield code="a">DE-29</subfield><subfield code="a">DE-188</subfield><subfield code="a">DE-578</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">QP364.7</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.07/93</subfield><subfield code="2">20</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XH 1500</subfield><subfield code="0">(DE-625)152870:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XH 3200</subfield><subfield code="0">(DE-625)152888:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Antibodies as carriers of cytotoxicity</subfield><subfield code="c">vol. ed. H.-H. Sedlacek ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Basel ; München [u.a.]</subfield><subfield code="b">Karger</subfield><subfield code="c">1992</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">VIII, 208 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Beiträge zur Onkologie</subfield><subfield code="v">43</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Literaturverz. S. [147] - 208</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antibodies, Monoclonal</subfield><subfield code="x">therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antibody-toxin conjugates</subfield><subfield code="x">Therapeutic use</subfield><subfield code="x">Testing</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer</subfield><subfield code="x">Chemotherapy</subfield><subfield code="x">Evaluation</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cytotoxicity, Immunologic</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neoplasms</subfield><subfield code="x">therapy</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Cytotoxizität</subfield><subfield code="0">(DE-588)4193696-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Monoklonaler Antikörper</subfield><subfield code="0">(DE-588)4040094-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Antikörper</subfield><subfield code="0">(DE-588)4002290-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Therapie</subfield><subfield code="0">(DE-588)4059798-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneistoffträger</subfield><subfield code="0">(DE-588)4278196-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Tumor</subfield><subfield code="0">(DE-588)4078460-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Therapie</subfield><subfield code="0">(DE-588)4059798-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Monoklonaler Antikörper</subfield><subfield code="0">(DE-588)4040094-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="3"><subfield code="a">Arzneistoffträger</subfield><subfield code="0">(DE-588)4278196-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Antikörper</subfield><subfield code="0">(DE-588)4002290-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Cytotoxizität</subfield><subfield code="0">(DE-588)4193696-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">Tumor</subfield><subfield code="0">(DE-588)4078460-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="1"><subfield code="a">Monoklonaler Antikörper</subfield><subfield code="0">(DE-588)4040094-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="2"><subfield code="a">Cytotoxizität</subfield><subfield code="0">(DE-588)4193696-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="3"><subfield code="a">Therapie</subfield><subfield code="0">(DE-588)4059798-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sedlacek, Hans-Harald</subfield><subfield code="d">1943-</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)1029511926</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Beiträge zur Onkologie</subfield><subfield code="v">43</subfield><subfield code="w">(DE-604)BV000000016</subfield><subfield code="9">43</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-003349792</subfield></datafield></record></collection>
id DE-604.BV005345499
illustrated Illustrated
indexdate 2025-02-03T16:22:41Z
institution BVB
isbn 3805555997
language English
oai_aleph_id oai:aleph.bib-bvb.de:BVB01-003349792
oclc_num 25992234
open_access_boolean
owner DE-19
DE-BY-UBM
DE-12
DE-355
DE-BY-UBR
DE-29
DE-188
DE-578
owner_facet DE-19
DE-BY-UBM
DE-12
DE-355
DE-BY-UBR
DE-29
DE-188
DE-578
physical VIII, 208 S. Ill., graph. Darst.
publishDate 1992
publishDateSearch 1992
publishDateSort 1992
publisher Karger
record_format marc
series Beiträge zur Onkologie
series2 Beiträge zur Onkologie
spellingShingle Antibodies as carriers of cytotoxicity
Beiträge zur Onkologie
Antibodies, Monoclonal therapeutic use
Antibody-toxin conjugates Therapeutic use Testing
Cancer Chemotherapy Evaluation
Cytotoxicity, Immunologic
Neoplasms therapy
Cytotoxizität (DE-588)4193696-6 gnd
Monoklonaler Antikörper (DE-588)4040094-3 gnd
Antikörper (DE-588)4002290-0 gnd
Therapie (DE-588)4059798-2 gnd
Krebs Medizin (DE-588)4073781-0 gnd
Arzneistoffträger (DE-588)4278196-6 gnd
Tumor (DE-588)4078460-5 gnd
subject_GND (DE-588)4193696-6
(DE-588)4040094-3
(DE-588)4002290-0
(DE-588)4059798-2
(DE-588)4073781-0
(DE-588)4278196-6
(DE-588)4078460-5
title Antibodies as carriers of cytotoxicity
title_auth Antibodies as carriers of cytotoxicity
title_exact_search Antibodies as carriers of cytotoxicity
title_full Antibodies as carriers of cytotoxicity vol. ed. H.-H. Sedlacek ...
title_fullStr Antibodies as carriers of cytotoxicity vol. ed. H.-H. Sedlacek ...
title_full_unstemmed Antibodies as carriers of cytotoxicity vol. ed. H.-H. Sedlacek ...
title_short Antibodies as carriers of cytotoxicity
title_sort antibodies as carriers of cytotoxicity
topic Antibodies, Monoclonal therapeutic use
Antibody-toxin conjugates Therapeutic use Testing
Cancer Chemotherapy Evaluation
Cytotoxicity, Immunologic
Neoplasms therapy
Cytotoxizität (DE-588)4193696-6 gnd
Monoklonaler Antikörper (DE-588)4040094-3 gnd
Antikörper (DE-588)4002290-0 gnd
Therapie (DE-588)4059798-2 gnd
Krebs Medizin (DE-588)4073781-0 gnd
Arzneistoffträger (DE-588)4278196-6 gnd
Tumor (DE-588)4078460-5 gnd
topic_facet Antibodies, Monoclonal therapeutic use
Antibody-toxin conjugates Therapeutic use Testing
Cancer Chemotherapy Evaluation
Cytotoxicity, Immunologic
Neoplasms therapy
Cytotoxizität
Monoklonaler Antikörper
Antikörper
Therapie
Krebs Medizin
Arzneistoffträger
Tumor
volume_link (DE-604)BV000000016
work_keys_str_mv AT sedlacekhansharald antibodiesascarriersofcytotoxicity